Advanced Medical Optics Announces Upcoming Speaking Engagements
November 29 2004 - 5:45PM
PR Newswire (US)
Advanced Medical Optics Announces Upcoming Speaking Engagements
SANTA ANA, Calif., Nov. 29 /PRNewswire-FirstCall/ -- Advanced
Medical Optics, Inc. (AMO) (NYSE:AVO), a global leader in
ophthalmic surgical devices and eye care products, today announced
that President and Chief Executive Officer James V. Mazzo will
conduct a series of investor meetings on Tuesday, November 30,
2004, and Monday, December 6, 2004. Slides from these meetings will
be posted on the company's Investors/Media site at
http://www.amo-inc.com/ beginning November 30, 2004, and will be
available through December 14, 2004. Mr. Mazzo will also present an
overview of the company at the First Albany Capital Annual Growth
Conference in New York on Tuesday, December 7, 2004, at 12:00 noon
ET. Corporate Vice President and Chief Marketing Officer Russ
Trenary will present at the Harris Nesbitt "Focus on Healthcare"
Investor Conference in New York on Wednesday, December 8, 2004,
11:00 a.m. ET. To access webcasts of both conference presentations
via the internet, please visit AMO's Investors/Media site at
http://www.amo-inc.com/. About Advanced Medical Optics Advanced
Medical Optics, Inc. (AMO) is a global leader in the development,
manufacturing and marketing of ophthalmic surgical and contact lens
care products. The company focuses on developing a broad suite of
innovative technologies and devices to address a wide range of eye
disorders. Products in the ophthalmic surgical line include
foldable intraocular lenses, phacoemulsification systems,
viscoelastics and related products used in cataract and refractive
surgery, and microkeratomes used in LASIK procedures for refractive
error correction. AMO owns or has the rights to such well-known
ophthalmic surgical product brands as Phacoflex(R), Clariflex(R),
Array(R), Sensar(R), Tecnis(R), CeeOn(R) and Verisyse(R)
intraocular lenses, the Sovereign(R) and Sovereign(R) Compact(TM)
phacoemulsification systems with WhiteStar(TM) technology, the
Healon(R) family of viscoelastics, the Baerveldt(R) glaucoma shunt
and the Amadeus(TM) microkeratome. Products in the contact lens
care line include disinfecting solutions, daily cleaners, enzymatic
cleaners and lens rewetting drops. Among the well-known contact
lens care product brands the company possesses are COMPLETE(R),
COMPLETE(R) Blink-N-Clean(R), COMPLETE(R) Moisture PLUS(TM),
Consept(R)F, Consept(R) 1 Step, Oxysept(R) 1 Step, UltraCare(R),
Ultrazyme(R), Total Care(R) and blink(TM) branded products. Amadeus
is a licensed product of, and a trademark of SIS, Ltd. Advanced
Medical Optics, Inc. is based in Santa Ana, California, and employs
approximately 2,800 worldwide. The company has direct operations in
about 20 countries and markets products in approximately 60
countries. For more information, visit http://www.amo-inc.com/.
Investor Contact: Erika Richmond (714) 247-8348 DATASOURCE:
Advanced Medical Optics, Inc. CONTACT: investors, Erika Richmond,
+1-714-247-8348, , for Advanced Medical Optics, Inc. Web site:
http://www.amo-inc.com/
Copyright
Advanced medical Optics (NYSE:AVO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Advanced medical Optics (NYSE:AVO)
Historical Stock Chart
From Jul 2023 to Jul 2024